Blogopmaak
N=1 Collaborative is looking for communication trainees
The N=1 Collaborative is a nonprofit whose mission is to transform the treatment of rare genetic disease by building a scalable and responsible pathway for individualized medicines. We are a team of clinicians, scientists, regulators, patient advocates from across academia, government, foundations, and biotech/pharma committed to openly sharing and iterating our work with the broader community in order to make individualized medicines routine worldwide.
N1C is looking for volunteers to help with science communication, social media and website management, and generation and curation of internal and public resources.
For more information, please contact info@n1collaborative.org.
posted on August 8, 2024
Two new DCRT papers have been published online
Team DCRT went for its annual outing to Leiden's escape rooms
N=1 Collaborative is looking for communication trainees
PhD Position in treatment-response fluid biomarkers for ASO treatments
Short report of the 3rd Dutch Antisense Therapeutics Symposium in Rotterdam
DCRT travel grants awarded to 3 PhD students
Dr Marlen Lauffer, a senior researcher at the Dutch Center for RNA Therapeutics, was invited to give a talk at the Genomics England research summit in London on the 9th of July. She presented DCRT's work on the identification of genes and diseases and guidelines for patient selection.
Our paper on patient selection guidelines for ASO-based treatments has been published in Human Mutation!
A special cake for Bianca Zardetto to celebrate the acceptance of her article in Human Mutation
DCRT at the 3rd Dutch Antisense Therapeutics Symposium in Rotterdam